The smartest thing for ZLCS to do is announce a partnership. The company needs to regain
compliance & this would get the share price over $1. They could put any number of clauses in it that give milestones for achieving clinical results, fda filings, & sales numbers, etc. Maybe we can get an announcement tomorrow since times running out before we'd be forced into doing a r/s.
"In accordance with Marketplace Rule 5810(c)(3)(A), we had a period of 180 calendar days, or until April 22, 2013, to regain compliance with the Rule. If at any time before April 22, 2013, the bid price of our common stock had closed at or above $1.00 per share for a minimum of 10 consecutive business days, NASDAQ would have provided written notification that we had achieved compliance with the Rule. We were not able to maintain the minimum closing bid price by April 22, 2013, and as a result, we voluntarily applied to transfer the listing of our common stock from the NASDAQ Global Market to the NASDAQ Capital Market. In connection with the transfer to the NASDAQ Capital Market, which occurred on April 23, 2013, we were granted an additional 180 days, or until October 21, 2013, to regain compliance by maintaining a minimum closing bid price of at least $1.00 for ten consecutive business days."
I couldn't disagree with you more if you are talking about Z-160. It would be absolutely stupid for ZLCS to try and find a partner this close to results. The only reason to do so would be if they know results will suck, but that would be illegal. We wouldn't get squat in terms of a partnership deal right now. If results are good, however, we could get a very lucrative deal.
This all ignores the fact that no biotech company would be dumb enough to sign a partnership for Z-160 before results are released. The first P2 trial failed, and while we all feel good about where the second set of P2 trials are headed, the fact that the first trial failed would give any interested companies a serious cause for concern until results are released.
I'm sure their going to do a r/s but it makes sense:
#1 sign a partnership for Z-160, #2 announce results from LSR trial , #3 do a reverse split, #4 raise additional funds, #5 announce results from PHN.